Skip to main content
SGLT2 inhibitors in type 2 diabetes linked to lower risk of developing GI cancers
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
SGLT2 inhibitors in type 2 diabetes linked to lower risk of developing GI cancers
User login
Username
Password
Reset your password
Concept
Lead
score
Type 2 Diabetes Mellitus
1
1
Cancer
0
0.94
Colorectal Cancer
0
0.74
Colon Cancer
0
0.71
Gastric Cancer
0
0.69
Hepatocellular Carcinoma
0
0.69
Noncolorectal Gastrointestinal Cancer
0
0.69
Pancreatic Cancer
0
0.69
Cancer Risk
0
0.67
Gastrointestinal Cancer
0
0.99
SGLT2 Inhibitor
0
0.98
Crohn Disease
0
0.16
Ulcerative Colitis
0
0.13
Colitis
0
0.1
Inflammatory Bowel Disease
0
0.1
Esophagus
0
0.07
Hospital
0
0.07
Orbit
0
0.07
Specialty
Lead
score
Gastroenterology
1
1
Diabetes & Endocrinology
0
0.9
Hematology-Oncology
0
0.7
Internal Medicine
0
0.8
Edit Tags